热门出版物 - 学术资源搜索

h5 指数:69
h5 中位数:92

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#6 Vascular Medicine

标题/作者	引用次数	年份
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) MF Piepoli, AW Hoes, S Agewall, C Albus, C Brotons, AL Catapano, ... Atherosclerosis 252, 207-274	4585	2016
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) AL Catapano, I Graham, G De Backer, O Wiklund, MJ Chapman, H Drexel, ... Atherosclerosis 253, 281-344	530	2016
HMG-coenzyme a reductase inhibition, type 2 diabetes, and bodyweight: Evidence from genetic analysis and randomised trials D Swerdlow, D Preiss, AD Hingorani, N Sattar Atherosclerosis 241 (1), e17	474	2015
The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society C Vlachopoulos, P Xaplanteris, V Aboyans, M Brodmann, R Cífková, ... Atherosclerosis 241 (2), 507-532	447	2015
Sex differences in cardiovascular risk factors and disease prevention Y Appelman, BB van Rijn, E Monique, E Boersma, SAE Peters Atherosclerosis 241 (1), 211-218	283	2015
New insights into the pathophysiology of dyslipidemia in type 2 diabetes MR Taskinen, J Borén Atherosclerosis 239 (2), 483-495	267	2015
A concise review of non-alcoholic fatty liver disease NN Than, PN Newsome Atherosclerosis 239 (1), 192-202	266	2015
Vascular endothelium–Gatekeeper of vessel health PA Cahill, EM Redmond Atherosclerosis 248, 97-109	192	2016
Saturated fatty acids trigger TLR4-mediated inflammatory response DM Rocha, AP Caldas, LL Oliveira, J Bressan, HH Hermsdorff Atherosclerosis 244, 211-215	178	2016
Sex differences in coronary artery disease: Pathological observations K Yahagi, HR Davis, E Arbustini, R Virmani Atherosclerosis 239 (1), 260-267	165	2015
Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial M Farnier, P Jones, R Severance, M Averna, E Steinhagen-Thiessen, ... Atherosclerosis 244, 138-146	161	2016
A randomized trial of coenzyme Q10 in patients with confirmed Statin Myopathy BA Taylor, L Lorson, CM White, PD Thompson Atherosclerosis 238 (2), 329-335	159	2015
Berberine, a plant alkaloid with lipid-and glucose-lowering properties: From in vitro evidence to clinical studies A Pirillo, AL Catapano Atherosclerosis 243 (2), 449-461	138	2015
Arterial stiffness in diabetes mellitus SB Prenner, JA Chirinos Atherosclerosis 238 (2), 370-379	138	2015
Familial hypercholesterolaemia: A global call to arms AJ Vallejo-Vaz, SRK Seshasai, D Cole, GK Hovingh, JJP Kastelein, ... Atherosclerosis 243 (1), 257-259	131	2015
A Mediterranean diet and risk of myocardial infarction, heart failure and stroke: A population-based cohort study TG Tektonidis, A Åkesson, B Gigante, A Wolk, SC Larsson Atherosclerosis 243 (1), 93-98	123	2015
The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA) M Al Rifai, MG Silverman, K Nasir, MJ Budoff, R Blankstein, M Szklo, ... Atherosclerosis 239 (2), 629-633	121	2015
Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology G De Backer, J Besseling, J Chapman, GK Hovingh, JJP Kastelein, ... Atherosclerosis 241 (1), 169-175	121	2015
The dark and bright side of atherosclerotic calcification G Pugliese, C Iacobini, CB Fantauzzi, S Menini Atherosclerosis 238 (2), 220-230	120	2015
Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries–Findings from the EUROASPIRE IV survey Ž Reiner, G De Backer, Z Fras, K Kotseva, L Tokgözoglu, D Wood, ... Atherosclerosis 246, 243-250	119	2016

1 - 20

计算机程序会自动估算并确定日期和引用次数。